BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $375,242 | -16.8% | 360,739 | +2.4% | 0.00% | – |
| Q2 2023 | $450,840 | +82.2% | 352,219 | +97.9% | 0.00% | – |
| Q1 2023 | $247,408 | +123604.0% | 177,992 | +15.5% | 0.00% | – |
| Q4 2022 | $200 | -99.9% | 154,076 | +8.3% | 0.00% | – |
| Q3 2022 | $210,000 | -27.6% | 142,223 | 0.0% | 0.00% | – |
| Q2 2022 | $290,000 | -67.6% | 142,223 | -56.5% | 0.00% | – |
| Q1 2022 | $895,000 | -53.4% | 326,695 | -16.7% | 0.00% | – |
| Q4 2021 | $1,921,000 | -56.0% | 392,132 | +13.6% | 0.00% | -100.0% |
| Q3 2021 | $4,365,000 | +34.4% | 345,115 | +64.2% | 0.00% | – |
| Q2 2021 | $3,248,000 | -53.0% | 210,153 | +0.1% | 0.00% | -100.0% |
| Q1 2021 | $6,906,000 | – | 209,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |